Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial

IMPORTANCE: High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and is widely applied in patients with COVID-19. OBJECTIVE: To assess whether helmet noninvasive ventilation can increase the days free of respiratory support in patients with COVID-19 comp...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA
Prif Awduron: Grieco, Domenico Luca, Menga, Luca S., Cesarano, Melania, Rosà, Tommaso, Spadaro, Savino, Bitondo, Maria Maddalena, Montomoli, Jonathan, Falò, Giulia, Tonetti, Tommaso, Cutuli, Salvatore L., Pintaudi, Gabriele, Tanzarella, Eloisa S., Piervincenzi, Edoardo, Bongiovanni, Filippo, Dell’Anna, Antonio M., Delle Cese, Luca, Berardi, Cecilia, Carelli, Simone, Bocci, Maria Grazia, Montini, Luca, Bello, Giuseppe, Natalini, Daniele, De Pascale, Gennaro, Velardo, Matteo, Volta, Carlo Alberto, Ranieri, V. Marco, Conti, Giorgio, Maggiore, Salvatore Maurizio, Antonelli, Massimo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2021
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7995134/
https://ncbi.nlm.nih.gov/pubmed/33764378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.4682
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg